Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril …

YH Lee, WR Chiou, CY Hsu, PL Lin… - European Heart …, 2022 - academic.oup.com
Aims Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril
was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy …
被引用次数：30 相关文章
[PDF] researchgate.net

[PDF][PDF] Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving …

YH Lee, WR Chiou, CY Hsu, PL Lin, HW Liang… - researchgate.net
Aims Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril
was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy …

Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril …

YH Lee, WR Chiou, CY Hsu, PL Lin… - European Heart …, 2022 - academic.oup.com
Aims Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril
was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy …
[PDF] heartcenter.org.tw

[PDF][PDF] Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving …

YH Lee, WR Chiou, CY Hsu, PL Lin, HW Liang… - heartcenter.org.tw
Aims Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril
was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy …

Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril …

YH Lee, WR Chiou, CY Hsu, PL Lin… - European Heart …, 2022 - europepmc.org
Aims Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril
was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy …

Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril …

YH Lee, WR Chiou, CY Hsu, PL Lin… - European Heart …, 2022 - scholar.nycu.edu.tw
Aims: Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril
was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy …

Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril …

L Ying-Hsiang, WR Chiou, H Chien-Yi… - European Heart …, 2022 - search.proquest.com
Aims Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril
was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy …

Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril …

YH Lee, WR Chiou, CY Hsu, PL Lin, HW Liang… - European Heart …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Aims</jats: title>< jats: p>
Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril was …

Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril …

YH Lee, WR Chiou, CY Hsu, PL Lin… - European heart …, 2022 - pubmed.ncbi.nlm.nih.gov
Aims Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril
was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy …

Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril …

YH Lee, WR Chiou, CY Hsu, PL Lin… - European Heart …, 2022 - hub.tmu.edu.tw
Aims: Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril
was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy …